中财网 中财网股票行情
昭衍新药(603127)财务分析指标    年份：
截止日期2025-03-312024-12-312024-09-302024-06-302024-03-31
营业总收入(万元)28733.72201833.38133515.6184935.6532480.91
营业收入(万元)28733.72201833.38133515.6184935.6532480.91
营业总成本(万元)31033.64176374.83122773.4380644.3029329.46
营业成本(万元)20513.29144456.0296825.1659142.3421815.70
净利润(万元)4035.262303.43-7516.63-16671.77-27135.87
归属于母公司的净利润(万元)4111.957407.54-7030.71-16974.26-27222.25
营业利润(万元)4938.2610434.73-6966.10-17715.47-29300.83
利润总额(万元)4938.3710403.91-6989.23-17735.11-29313.00
少数股东损益(万元)0.00-432.03-393.69-249.57-114.11
基本每股收益(元)0.05(元)0.10(元)-0.09(元)-0.23(元)-0.36(元)
稀释每股收益(元)0.05(元)0.10(元)-0.09(元)-0.23(元)-0.36(元)
非经常性损益(万元)1545.69----2865.23--
扣除非经常性损益后净利润(万元)2566.262357.34-11346.82-19839.49-28066.67
总资产(万元)942465.86939615.26952518.48966127.37973325.45
总负债(万元)131545.27131696.44153435.02174603.23173952.63
归属于母公司股东权益合计(万元)810883.63807881.86800243.57791601.24799314.46
股东权益合计(万元)810920.59807918.83799083.46791524.14799372.82
实收资本(股本)(万元)74947.7374947.7374947.7374988.8774988.87
资本公积(万元)523766.59523766.59525002.00526712.82526712.82
未分配利润(万元)213608.86209496.91197412.01187425.19189174.90
经营活动产生的现金流量净额(万元)6514.9233892.8719232.5715771.6611995.35
经营活动现金流入小计(万元)42980.50181138.70136769.1491913.9449259.00
经营活动现金流出小计(万元)36465.58147245.83117536.5776142.2737263.64
投资活动产生的现金流量净额(万元)-33395.98-196302.40-95005.08-74567.20-6756.23
投资活动现金流入小计(万元)61761.37336550.20250809.81191448.6111145.35
投资活动现金流出小计(万元)95157.35532852.60345814.89266015.8117901.58
筹资活动产生的现金流量净额(万元)-1866.51-26562.75-24882.81-10725.03-3792.84
筹资活动现金流入小计(万元)----------
筹资活动现金流出小计(万元)1866.5126562.7524882.8110725.033792.84
期末现金及现金等价物余额(万元)67657.1296520.31184012.45215819.51286531.42
最后修改日期2025-04-292025-03-282024-10-312024-09-022024-04-29
↑返回页顶↑

转至昭衍新药（603127）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。